Vis enkel innførsel

dc.contributor.authorStamatakis, Emmanuel
dc.contributor.authorGale, Joanne
dc.contributor.authorBauman, Adrian
dc.contributor.authorEkelund, Ulf
dc.contributor.authorHamer, Mark
dc.contributor.authorDing, Ding
dc.date.accessioned2020-04-24T09:23:05Z
dc.date.available2020-04-24T09:23:05Z
dc.date.created2019-06-06T13:43:38Z
dc.date.issued2019
dc.identifier.citationJournal of the American College of Cardiology. 2019, 73(16), 2062-2072.en_US
dc.identifier.issn0735-1097
dc.identifier.urihttps://hdl.handle.net/11250/2652383
dc.descriptionThis is an open access article under theCC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).en_US
dc.description.abstractBackground: It is unclear what level of moderate to vigorous intensity physical activity (MVPA) offsets the health risks of sitting. Objectives: The purpose of this study was to examine the joint and stratified associations of sitting and MVPA with all-cause and cardiovascular disease (CVD) mortality, and to estimate the theoretical effect of replacing sitting time with physical activity, standing, and sleep. Methods: A longitudinal analysis of the 45 and Up Study calculated the multivariable-adjusted hazard ratios (HRs) of sitting for each sitting-MVPA combination group and within MVPA strata. Isotemporal substitution modeling estimated the per-hour HR effects of replacing sitting. Results: A total of 8,689 deaths (1,644 due to CVD) occurred among 149,077 participants over an 8.9-year (median) follow-up. There was a statistically significant interaction between sitting and MVPA only for all-cause mortality. Sitting time was associated with both mortality outcomes in a nearly dose-response manner in the least active groups reporting <150 MVPA min/week. For example, among those reporting no MVPA, the all-cause mortality HR comparing the most sedentary (>8 h/day) to the least sedentary (<4 h/day) groups was 1.52 (95% confidence interval: 1.13 to 2.03). There was inconsistent and weak evidence for elevated CVD and all-cause mortality risks with more sitting among those meeting the lower (150 to 299 MVPA min/week) or upper (≥300 MVPA min/week) limits of the MVPA recommendation. Replacing sitting with walking and MVPA showed stronger associations among high sitters (>6 sitting h/day) where, for example, the per-hour CVD mortality HR for sitting replaced with vigorous activity was 0.36 (95% confidence interval: 0.17 to 0.74). Conclusions: Sitting is associated with all-cause and CVD mortality risk among the least physically active adults; moderate-to-vigorous physical activity doses equivalent to meeting the current recommendations attenuate or effectively eliminate such associations.en_US
dc.language.isoengen_US
dc.subjectcardiovascular diseaseen_US
dc.subjectepidemiologyen_US
dc.subjectexerciseen_US
dc.subjectmortalityen_US
dc.subjectphysical activityen_US
dc.subjectsedentary behavioren_US
dc.titleSitting Time, Physical Activity, and Risk of Mortality in Adultsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2019 The Authors.en_US
dc.source.pagenumber2062-2072en_US
dc.source.volume73en_US
dc.source.journalJournal of the American College of Cardiologyen_US
dc.source.issue16en_US
dc.identifier.doi10.1016/j.jacc.2019.02.031
dc.identifier.cristin1703183
dc.description.localcodeSeksjon for idrettsmedisinske fag / Department of Sports Medicineen_US
cristin.unitcode150,34,0,0
cristin.unitnameSeksjon for idrettsmedisinske fag
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel